調査レポートカテゴリー： visiongain, 世界, 医療/バイオ

NEUROMODULATION DEVICES: WORLD INDUSTRY AND MARKET 2015-2025

世界の神経調節用医療装置市場：脊髄刺激療法(SCS)、脳深部刺激療法（DBS）、迷走神経刺激療法(VNS)、仙骨神経刺激療法(SNS)

◆タイトル：NEUROMODULATION DEVICES: WORLD INDUSTRY AND MARKET 2015-2025
◆商品コード：VGAIN4120212
◆調査・発行会社：visiongain
◆発行日：2014年11月
◆ページ数：198
◆レポート形式：PDF / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Sigle User	GBP3,499 ⇒換算￥489,860	見積依頼/購入/質問フォーム
Departmental/Five User	GBP3,899 ⇒換算￥545,860	見積依頼/購入/質問フォーム
Site License	GBP4,999 ⇒換算￥699,860	見積依頼/購入/質問フォーム

※Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、世界の神経調節用医療装置市場について調査・分析し、イントロダクション、セグメント別市場分析、地域別市場分析、市場環境分析、専門家の見解、主要企業分析データなどをお届けいたします。

Neuromodulation devices – your guide to trends, progress and revenue prospects
See the future of medical devices to stimulate and treat the central nervous system (CNS). Those treatments hold high potential. Now you can explore sales forecasts and explore that industry’s research and development (R&D).

Visiongain’s new report predicts those revenues to 2025 at overall world market, submarket and national level. There you stay ahead in data and analysis on therapies, discovering medical, technological and commercial potentials and opportunities.

Read on to explore those neuronal treatments, seeing how high that industry’s sales can go.

Forecasts and other analyses to help your research, knowledge and influence
Avoid struggles to find business information on neuromodulation and neurostimulation. Instead discover what’s happening in treating brain and other nervous system disorders. And now you can make your research, market appraisal and analysis easier and quicker.

Besides forecasting to 2025, our new study gives you recent results, growth rates, market shares and discussions. You get 75 charts, 28 tables and interviews with two companies.

Discover how competition and technological advances shape that industry. Also benefit your reputation for technological and commercial knowledge. See what’s possible from now.

Forecasting of that world market and its segments
Our study predicts overall world revenue to 2025 for neuromodulating and neurostimulating technologies and their uses.

There you also find individual revenue predictions to 2025 for five submarkets at world level:
• Spinal cord stimulation (SCS)
• Deep brain stimulation (DBS)
• Vagal nerve stimulation (VNS)
• Sacral nerve stimulation (SNS)
• Other techniques for modifying CNS activity.

You investigate the most promising and lucrative parts of the neuromodulators industry. See how it can progress. Our study predicts high, rising sales there. You explore how, where, when and why rapid market expansion can occur.

That work also splits its overall world market into geographical revenue predictions.

Healthcare in national markets – what outlooks for that business?
Our analyses also show you individual revenue forecasts to 2025 for 12 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy, Spain and Ireland, also with EU regional prediction
• Brazil, Russia, India and China (BRIC nations).

There you find countries with highest revenues, demand and potential sales. Explore progress, needs and opportunities, seeing how you can gain.

And how do changes, challenges and technological advances affect that industry and market?

Forces, events and issues – developments influencing that medical field
The new report explains policies, trends and R&D shaping that industry and market, including these:
• Widening applications in treating pain, depression, epilepsy, incontinence, hearing disorders, heart conditions and neurodegenerative diseases, inc. Parkinson’s
• Market trends – ageing populations raising demand, personalised healthcare, regulations and changes in that medical devices sector
• Emerging technology – cochlear implants, transmagnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and ultrasonic applications.

There you assess that industry’s strengths, weaknesses, opportunities and threats, also exploring social, technological, economic and political questions. Those analyses give you feel for that market – its progress and potential. That way you’re less likely to fall behind.

Neuromodulation technology and its uses – companies and 2018 market value
What happens next? From 2015 those treatments hold great potential for investments, medical advances and sales. Our new report predicts the world market for those products will reach $8.1bn in 2018, with rapid expansion to 2025.

That work also explores activities and potentials of these companies and others:
• Medtronic
• Boston Scientific
• St. Jude Medical
• Cyberonics
• Stryker Corporation
• SetPoint Medical
• Functional Neuromodulation
• Neurotherapies Reset.

【レポートの目次】

1. Report Overview
1.1 Overview of the World Market for Neuromodulation Devices
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Study for?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain

2. Introduction to Neuromodulation
2.1 Neuromodulation
2.2 Techniques Used in Neuromodulation
2.2.1 Electrical Stimulation Techniques
2.2.1.1 Brain and Spinal Cord Therapies
2.2.1.2 Cranial Nerve Stimulation
2.2.1.3 Functional Electrical Stimulation
2.2.2 Pharmacological Therapy
2.3 Application of Neuromodulation
2.3.1 Pain
2.3.2 Depression
2.3.3 Epilepsy
2.3.4 Faecal and Urinary Incontinence
2.3.5 Hearing Disorders – Profound Deafness
2.3.6 Cardiovascular Diseases – Arrhythmia and Angina
2.3.7 Neurodegenerative Diseases – Parkinson’s Disease

3. The World Neuromodulation Devices Market, 2014-2025
3.1 Global Neuromodulation Devices Market: 2014
3.2 Global Neuromodulation Devices Forecast: 2014-2025
3.3 Neuromodulation Devices: Industry Trends, 2014-2025
3.3.1 Industry Trends – Ageing Population
3.3.2 Industry Trends – Personalised Healthcare
3.3.3 Industry Trends – Stricter Regulations
3.3.4 Industry Trends – Economic Troubles
3.3.5 Industry Trends – Mergers and Acquisitions

4. Neuromodulation Devices: Outlook for Market Segments, 2014-2025
4.1 Spinal Cord Stimulation (SCS)
4.1.1 SCS Market Forecast: 2014-2025
4.1.2 SCS Market Trends: 2014-2025
4.2 Deep Brain Stimulation (DBS)
4.2.1 DBS Market Forecast: 2014-2025
4.2.2 DBS Market Trends: 2014-2025
4.3 Vagus Nerve Stimulation (VNS)
4.3.1 VNS Market Forecast: 2014-2025
4.3.2 VNS Market Trends: 2014-2025
4.4 Sacral Nerve Stimulation (SNS)
4.4.1 SNS Market Forecast: 2014-2025
4.4.2 SNS Market Trends: 2014-2025
4.5 Other Neuromodulation Techniques
4.5.1 Cochlear Implants
4.5.2 Transmagnetic Stimulation (TMS)
4.5.3 Transcranial Direct Current Stimulation (tDCS)
4.5.4 Ultrasonic Neuromodulation
4.5.5 Other Neuromodulation Techniques Forecast: 2014-2025

5. Leading National Markets, 2014-2025
5.1 Neuromodulation Devices: Leading Markets, 2014
5.2 The US Neuromodulation Devices Market: 2014-2025
5.2.1The US Neuromodulation Devices Market: 2014
5.2.2 The US Neuromodulation Devices Market Forecast: 2014-2025
5.2.3 The Effects of Regulations on the US Market
5.3 The Japanese Neuromodulation Devices Market: 2014-2025
5.3.1 The Japanese Neuromodulation Devices Market: 2014
5.3.2 The Japanese Neuromodulation Devices Market Forecast: 2014-2025
5.3.3 The Effects of Regulations on the Japanese Market
5.4 The European Neuromodulation Devices Market: 2014-2025
5.4.1 The European Neuromodulation Devices Market: 2014
5.4.2 The European Neuromodulation Devices Market Forecast: 2014-2025
5.5 The German Neuromodulation Devices Market: 2014-2025
5.5.1 The German Neuromodulation Devices Market: 2014
5.5.2 The German Neuromodulation Devices Market Forecast: 2014-2025
5.6 The French Neuromodulation Devices Market: 2014-2025
5.6.1 The French Neuromodulation Devices Market: 2014
5.6.2 The French Neuromodulation Devices Market Forecast: 2014-2025
5.6.3 The French Neuromodulation Devices Market – the Economy and its Implications
5.7 The Italian Neuromodulation Devices Market: 2014-2025
5.7.1 The Italian Neuromodulation Devices Market: 2014
5.7.2 The Italian Neuromodulation Devices Market Forecast: 2014-2025
5.7.3 The Italian Neuromodulation Devices Market Outlook
5.8 The UK Neuromodulation Devices Market: 2014-2025
5.8.1 The UK Neuromodulation Devices Market: 2014
5.8.2 The UK Neuromodulation Devices Market Forecast: 2014-2025
5.8.3 The UK Neuromodulation Devices Market – Political Challenges
5.9 The Spanish Neuromodulation Devices Market: 2014-2025
5.9.1 The Spanish Neuromodulation Devices Market: 2014
5.9.2 The Spanish Neuromodulation Devices Market Forecast: 2014-2025
5.9.3 The Spanish Neuromodulation Devices Market Outlook
5.10 The Irish Neuromodulation Devices Market: 2014-2025
5.10.1 The Irish Neuromodulation Devices Market: 2014
5.10.2 The Irish Neuromodulation Devices Market Forecast: 2014-2025
5.10.3 The Irish Neuromodulation Devices Market Benefiting from-Foreign Investment
5.11 The Brazilian Neuromodulation Devices Market: 2014-2025
5.11.1 The Brazilian Neuromodulation Devices Market: 2014
5.11.2 The Brazilian Neuromodulation Devices Market Forecast: 2014-2025
5.11.3 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
5.12 The Chinese Neuromodulation Devices Market: 2014-2025
5.12.1 The Chinese Neuromodulation Devices Market: 2014
5.12.2 The Chinese Neuromodulation Devices Market Forecast: 2014-2025
5.12.3 The Chinese Neuromodulation Devices Market Forecast: a Wall to Foreign Investment?
5.13 The Indian Neuromodulation Devices Market: 2014-2025
5.13.1 The Indian Neuromodulation Devices Market: 2014
5.13.2 The Indian Neuromodulation Devices Market Forecast: 2014-2025
5.13.3 The Indian Neuromodulation Devices Market: What’s Possible in that Rising Industrial Power?
5.14 The Russian Neuromodulation Devices Market Forecast: 2014-2025
5.14.1 The Russian Neuromodulation Devices Market: 2014
5.14.2 The Russian Neuromodulation Devices Market Forecast: 2014-2025
5.14.3 The Russian Neuromodulation Devices Market Outlook: Foreign Restrictions – Return of an Iron Curtain?

6. Neuromodulation Devices Market: Manufacturers
6.1 Medtronic
6.1.1 Sales and Recent Performance Analysis: 2014
6.1.2 Medtronic International Operations
6.1.3 Medtronic – Neuromodulation Performance
6.1.4 Medtronic – News
6.1.4.1 Medtronic Mergers
6.1.4.2 Expansion into DBS Market
6.1.4.3 Medtronic Products
6.1.5 Medtronic – Market Risk
6.2 Boston Scientific
6.2.1 Sales and Recent Performance Analysis: 2014
6.2.2 Boston Scientific International Operations
6.2.3 Boston Scientific – Neuromodulation Performance
6.2.4 Boston Scientific News
6.2.4.1 Boston Scientific Acquisitions
6.2.4.2 Expansion into DBS Market
6.2.4.3 Boston Scientific Products
6.2.5 Boston Scientific – Market Risk
6.3 St. Jude Medical (SJM)
6.3.1 Sales and Recent Performance Analysis: 2014
6.3.2 SJM International Operations
6.3.3 SJM – Neuromodulation Performance
6.3.4 SJM News
6.3.4.1 SJM Acquisitions
6.3.4.2 SJM Products
6.3.5 SJM – Market Risk
6.4 Cyberonics
6.4.1 Sales and Recent Performance Analysis: 2014
6.4.2 Cyberonics International Operations
6.4.3 Cyberonics – Neuromodulation Performance
6.4.4 Cyberonics News
6.4.4.1 Cyberonics Investments
6.4.4.2 Cyberonics Products
6.4.5 Cyberonics – Market Risk
6.5 Other Companies
6.5.1 Stryker Corporation
6.5.2 Nevro Corp.
6.5.3 SetPoint Medical
6.5.4 Functional Neuromodulation
6.5.5 Neurotherapies Reset
6.5.6 Wiringless Implantable Stretchable Electronics (WISE)
6.5.7 SceneRay
6.5.8 Mindray

7. Qualitative Analysis of the Neuromodulation Devices Market
7.1 SWOT Analysis of the Neuromodulation Devices Market
7.1.1 Strengths of the Market
7.1.1.1 An Ageing Population
7.1.1.2 Alternative Form of Treatment
7.1.1.3 Convenience
7.1.2 Weaknesses
7.1.2.1 Research and Development (R&D)
7.1.2.2 Oligarchic Market
7.1.3 Opportunities in the Neuromodulation Devices Market
7.1.3.1 The Advancement of Research
7.1.3.2 A Shift towards Personalisation
7.1.4 Threats Facing the Neuromodulation Devices Market
7.1.4.1 The Challenge of Regulation
7.2 STEP Analysis of the Neuromodulation Devices Market
7.2.1 Social Factors: The Cost of Living Longer
7.2.2 Technological Developments: The Bionic Man
7.2.3 Economic Pressure: The Price of Health
7.2.4 Political Issues: Government Influences

8. Opinions from Our Industry Survey
8.1 Interview with Spokesman from a Medical Device Company
8.1.1 The Cochlear Implant Market
8.1.2 Cochlear Implant Technology
8.1.3 Products and Competition
8.1.4 Future Cochlear Implant Market
8.2 Interview with Martin Dobelle, Avery Biomedical
8.2.1 The Neuromodulation Devices Market
8.2.2 Phrenic Nerve Stimulation and the Breathing Pacemaker System
8.2.3 Patient Perception and Regulation
8.2.4 Future Projections for the Neuromodulation Devices Market

9. Conclusions of the Study
9.1 DBS and VNS – The Future of the Market
9.2 The US – Still the Largest National Market
9.3 China and India will Lead the Emerging Markets
9.4 Treatment – It’s Personal
9.5 The Neuromodulation Devices R&D Pipeline Remains Strong
9.6 Concluding Remarks

List of Tables
Table 1.1 Forecast Regional and National Neuromodulation Devices: Market Sizes ($bn), Annual Growth (%), CAGRs (%), 2013-2019
Table 1.2 Forecast Regional and National Neuromodulation Devices: Market Sizes ($bn), Annual Growth (%), CAGR (%), 2019-2025
Table 1.3 Currency Exchange Rates: Average Exchange Rate to USD, 2014
Table 3.1 The Global Neuromodulation Devices Markets: Revenue Forecast ($bn), Annual Growth (%), CAGRs (%), 2014-2025
Table 3.2 Neuromodulation Submarket Revenue ($bn) and Market Share (%), 2013, 2019 and 2025
Table 4.1 SCS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.2 The DBS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.3 The VNS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.4 The SNS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.5 The Other Neuromodulation Devices Market: Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.1 Neuromodulation Devices Market Revenue ($bn) and Market Share (%) by Leading Country, 2013, 2019 and 2025
Table 5.2 The US Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.3 The Japanese Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.4 The EU Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.5 The German Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.6 The French Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.7 The Italian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.8 The UK Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.9 The Spanish Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.10 The Irish Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.11 The Brazilian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.12 The Chinese Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.13 The Indian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.14 The Russian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 6.1 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Table 6.2 Boston Scientific Neuromodulation Revenue ($bn), 2011-2013
Table 6.3 SJM Neuromodulation Revenue ($bn), 2011-2013
Table 6.4 Cyberonics Neuromodulation Revenue ($bn), 2010-2014
Table 7.1 SWOT Analysis of the Neuromodulation Devices Market, 2014
Table 7.2 STEP Analysis of the Neuromodulation Devices Market, 2014
Table 9.1 National Neuromodulation Market Revenues ($bn) and Market Shares (%), 2013, 2019 and 2025

List of Figures
Figure 1.1 Neuromodulation Devices Market Segmentation, 2014
Figure 3.1 Global Neuromodulation Devices Market Share (%) Segmentation, 2013
Figure 3.2 The Global Neuromodulation Devices Market: Revenue Forecast ($bn), 2014-2025
Figure 3.3 Global Neuromodulation Devices Market Share (%) Segmentation, 2019
Figure 3.4 Global Neuromodulation Devices Market Share (%) Segmentation, 2025
Figure 3.5 Global Neuromodulation Devices Market: Drivers and Restraints, 2014-2025
Figure 4.1 SCS Devices Market Share (%) Segmentation, 2014
Figure 4.2 SCS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.3 DBS Devices Market Share (%) Segmentation, 2014
Figure 4.4 DBS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.5 VNS Devices Market Share (%) Segmentation, 2014
Figure 4.6 VNS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.7 SNS Devices Market Share (%) Segmentation, 2014
Figure 4.8 SNS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.9 Other Neuromodulation Devices Market Share (%) Segmentation, 2014
Figure 4.10 Other Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.1 Developed National Markets: Drivers and Restraints, 2014-2025
Figure 5.2 Emerging National Markets: Drivers and Restraints, 2014-2025
Figure 5.3 US Global Neuromodulation Devices Market Share (%), 2014
Figure 5.4 The US Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.5 Japanese Global Neuromodulation Devices Market Share (%), 2014
Figure 5.6 The Japanese Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.7 The EU Global Neuromodulation Devices Market Share (%), 2014
Figure 5.8 The EU Regional Neuromodulation Devices Market Shares (%), 2014
Figure 5.9 The EU Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.10 The German Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.11 German Global Neuromodulation Devices Market Share (%), 2014
Figure 5.12 The German Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.13 The French Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.14 French Global Neuromodulation Devices Market Share (%), 2014
Figure 5.15 The French Neuromodulation Device Revenue Forecast ($bn), 2014-2025
Figure 5.16 The Italian Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.17 Italian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.18 The Italian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.19 The UK Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.20 UK Global Neuromodulation Devices Market Share (%), 2014
Figure 5.21 The UK Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.22 The Spanish Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.23 Spanish Global Neuromodulation Devices Market Share (%), 2014
Figure 5.24 Spanish Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.25 The Irish Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.26 Irish Global Neuromodulation Devices Market Share (%), 2014
Figure 5.27 Irish Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.28 Brazilian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.29 Brazilian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.30 Chinese Global Neuromodulation Devices Market Share (%), 2014
Figure 5.31 Chinese Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.32 Indian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.33 Indian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.34 Russian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.35 Russian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 6.1 Medtronic Revenue ($bn), 2010-2014
Figure 6.2 Medtronic Operating Sectors (%), 2014
Figure 6.3 Medtronic Sales Shares (%), 2014
Figure 6.4 Medtronic Geographical Sales Shares (%), 2014
Figure 6.5 Medtronic Neuromodulation Revenue Shares (%) within Restorative Therapies, 2014
Figure 6.6 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Figure 6.7 Boston Scientific Revenue ($bn), 2009-2013
Figure 6.8 Boston Scientific Operating Sectors (%), 2014
Figure 6.9 Boston Scientific Sector Shares (%), 2014
Figure 6.10 Boston Scientific World Sales Shares (%), 2013
Figure 6.11 Boston Scientific Geographical Sales Shares (%), 2013
Figure 6.12 Boston Scientific Neuromodulation Revenue ($bn), 2011-2013
Figure 6.13 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2014
Figure 6.14 St. Jude Medical Revenue ($bn), 2009-2013
Figure 6.15 St. Jude Medical Operating Sectors (%), 2014
Figure 6.16 St. Jude Medical World Sales Shares (%), 2013
Figure 6.17 St. Jude Medical Geographical Sales Shares (%), 2013
Figure 6.18 St. Jude Medical Revenues ($bn), 2011-2013
Figure 6.19 St. Jude Medical Sales Distribution ($bn), Q1 2014 to Q3 2014
Figure 6.20 St. Jude Medical Neuromodulation Revenue ($bn), 2011-2013
Figure 6.21 St. Jude Medical Neuromodulation Devices Quarterly Analysis ($bn), 2013-2014
Figure 6.22 Cyberonics Revenue ($bn), 2010-2014
Figure 6.23 Cyberonics World Sales Shares (%), 2014
Figure 6.24 Cyberonics Sales Distribution ($bn), 2012-2014
Figure 9.1 World Neuromodulation Devices Market Share (%) Segmentation, 2025

【レポートのキーワード】

神経調節、医療装置（デバイス）、脊髄刺激療法(SCS)、脳深部刺激療法（DBS）、迷走神経刺激療法(VNS)、仙骨神経刺激療法(SNS)

★調査レポート[世界の神経調節用医療装置市場：脊髄刺激療法(SCS)、脳深部刺激療法（DBS）、迷走神経刺激療法(VNS)、仙骨神経刺激療法(SNS)] ( NEUROMODULATION DEVICES: WORLD INDUSTRY AND MARKET 2015-2025 / VGAIN4120212) 販売に関する免責事項

[世界の神経調節用医療装置市場：脊髄刺激療法(SCS)、脳深部刺激療法（DBS）、迷走神経刺激療法(VNS)、仙骨神経刺激療法(SNS)] ( NEUROMODULATION DEVICES: WORLD INDUSTRY AND MARKET 2015-2025 / VGAIN4120212) についてEメールでお問い合わせ

◆関連調査資料◆

神経調節装置の世界市場：脳深部刺激、脊髄、仙椎神経、胃部用途
VGAIN6041533 / visiongain / 2016年3月 / ...Neuromodulation devices – your 2016 guide to trends, opportunities and future revenuesDiscover the future of medical devices to stimulate and treat the central nervous system. Neuromodulation devices hold high, rising sales potential. Now you can explore forecasts and see predicted revenues. Assess the expected gains. Visiongain’s updated report predicts those revenues to 2026 at overall world market, submarket and national level. With our new survey you stay ahead in that CNS data and analysis, discovering medical, technological and commercial opportunities and prospects. With that study you explore what the future holds for those companies. Read on now to investigate neuronal...

神経調節装置の世界市場2017-2027
VGAIN712051 / visiongain / 2017年11月 / visiongain社が発行した当調査レポートでは、神経調節装置の世界市場について調査・分析し、神経調節装置の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。・レポートの概要・イントロダクション・神経調節装置の世界市場　（市場規模予測、市場動向、市場の成長要因・阻害要因など）・神経調節装置の世界市場：セグメント別市場分析・神経調節装置の世界市場：地域別市場分析、市場規模予測・市場環境分析・専門家の見解・主要企業分析...How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 195-page report you will receive 33 tables and 61 figures all unavailable elsewhere. The 195-page report provides clear detailed insight into the neuromodulation devices market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand new report today you stay better informed and ready to act. The revenue of the neuromodulation devices market in 2016 was estimated at $3.77bn and is expected to grow at a CAGR of 11.6%...

電気生理学装置の世界市場予測2017-2026：モニタリング装置（心エコー検査、診断用カテーテル、ホルター心電計、イベントモニター）および治療装置（ペースメーカー、ICD、アブレーションカテーテル、CRT-Ds、CRT-P）の収益予測
VGAIN61210 / visiongain / 2016年12月 / 当調査レポートでは、電気生理学装置の世界市場について調査・分析し、電気生理学装置の世界市場規模、市場動向、市場予測、市場環境分析、専門家の見解、関連企業情報などを含め、以下の構成でお届けいたします。...Electrophysiology Devices – our new study reveals trends, R&D progress, and predicted revenues Where is the electrophysiology devices market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 147-page report provides 103 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results,...

世界の疼痛管理用デバイス市場予測：鎮痛剤注入ポンプ/脊髄刺激/高周波アブレーション等
VISG409049 / visiongain / 2014年6月 / ...Pain Management Devices - new study showing you trends, R&D progress, and predicted revenues Where is the market for pain management devices heading? What are the commercial prospects for this market and related technologies? Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects. Our 226 page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket and national level. You will see financial results, interviews, trends, opportunities and revenue predictions....

心血管疾患用医療機器の世界市場予測2017-2027：検査装置、診断装置、手術装置
VGAIN702045 / visiongain / 2016年12月 / 当調査レポートでは、心血管疾患用医療機器の世界市場について調査・分析し、心血管疾患用医療機器の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。・レポートの概要・イントロダクション・心血管疾患用医療機器の世界市場　（市場規模予測、市場動向、市場の成長要因・阻害要因など）・心血管疾患用医療機器の世界市場：セグメント別市場分析・心血管疾患用医療機器の世界市場：地域別市場分析、市場規模予測・市場環境分析・専門家の見解・主要企業分析...The global cardiovascular devices market was valued at $40.05bn in 2016. Visiongain estimates that this market will grow at a CAGR of 6.4% in the first half of the forecast period and reach $54.22bn in 2021.This market is estimated to grow faster in the second half of the forecast period, growing at a CAGR of 7.1% and reach $81.38bn in 2027. The global cardiovascular devices market is estimated to grow at a CAGR of 6.7% from 2017 to 2027. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this...

心血管系医療デバイスの世界市場：心臓律動管理、補綴装置、インターベンショナル心血管用製品、モニタリング、診断機器
VGAIN5112514 / visiongain / 2015年11月 / 当調査レポートでは、心血管系医療デバイスの世界市場について調査・分析し、以下の構成でお届けいたします。・レポートの概要・イントロダクション・心血管系医療デバイスの世界市場　（市場規模予測、市場の成長要因・阻害要因など）・心血管系医療デバイスの世界市場：デバイス種類別市場分析・心血管系医療デバイスの世界市場：地域別市場分析、市場規模予測・心血管系医療デバイスの世界市場：環境分析・心血管系医療デバイスの世界市場：専門家の見解・心血管系医療デバイスの世界市場：主要企業分析...Cardiovascular medical devices – how to discover that technology’s commercial potential What is the future of devices for the human circulatory system? In visiongain’s new study you discover technological and commercial predictions from 2015. See what is possible. That way you stay ahead for data, benefiting your work and authority. For those medical devices you explore sales results, developments, opportunities and revenue forecasts to 2025. Succeed through discovering companies’ trends, progress and potential gains. Forecasts and other analysis showing potential revenues from those cardio products Discover how to help your reputation for commercial insight. Our study’s purpose is showing you...

薬剤・装置複合製品の世界市場2017-2027
VGAIN7081119 / visiongain / 2017年8月 / visiongain社が発行した当調査レポートでは、薬剤・装置複合製品の世界市場について調査・分析し、薬剤・装置複合製品の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。・レポートの概要・イントロダクション・薬剤・装置複合製品の世界市場　（市場規模予測、市場動向、市場の成長要因・阻害要因など）・薬剤・装置複合製品の世界市場：セグメント別市場分析・薬剤・装置複合製品の世界市場：地域別市場分析、市場規模予測・市場環境分析・専門家の見解・主要企業分析...The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere. The 151-page report provides clear detailed insight into the global drug-device combination market. Discover...

泌尿器科用機器の世界市場予測（～2026）：尿失禁、良性前立腺過形成（BPH）、腎臓結石、前立腺がん
VGAIN61209 / visiongain / 2016年12月 / 当調査レポートでは、泌尿器科用機器の世界市場について調査・分析し、泌尿器科用機器の世界市場規模、市場動向、市場予測、市場環境分析、専門家の見解、関連企業情報などを含め、以下の構成でお届けいたします。...The global urology devices market is expected to grow at a CAGR of 5.8% from 2020-2026 and CAGR of 6.2% from 2016-2020. The market is expected to grow at a CAGR of 6.0% from 2016 to 2026. The market is estimated at $6,126.4 million in 2016, $7,793.0 million in 2020, and $10,971.3 million in 2026. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new report you find 200-page report you will receive 91 tables and 80 charts – all unavailable elsewhere. The 200...

バイオMEMS及びマイクロフルイディクスの世界市場予測
VGAIN7081154 / visiongain / 2017年7月 / visiongain社が発行した当調査レポートでは、バイオMEMS及びマイクロフルイディクスの世界市場について調査・分析し、バイオMEMS及びマイクロフルイディクスの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。・レポートの概要・イントロダクション・バイオMEMS及びマイクロフルイディクスの世界市場　（市場規模予測、市場動向、市場の成長要因・阻害要因など）・バイオMEMS及びマイクロフルイディクスの世界市場：セグメント別市場分析・バイオMEMS及びマイクロフルイディクスの世界市場：地域別市場分析、市場規模予測・市場環境分析・専門家の見解・主要企業分析...Bio-MEMS and Microfluidics – our new study reveals trends, R&D progress, and predicted revenues Where is the Bio-MEMS and Microfluidics market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 206-page report provides 204 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See...

テレメディスンデバイス（遠隔医療機器）の世界市場2018-2028
VGAIN803044 / visiongain / 2018年2月 / visiongain社が発行した当調査レポートでは、テレメディスンデバイス（遠隔医療機器）の世界市場について調査・分析し、テレメディスンデバイス（遠隔医療機器）の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。・レポートの概要・テレメディスンデバイス（遠隔医療機器）のイントロダクション・テレメディスンデバイス（遠隔医療機器）：世界における市場2017-2028 ・テレメディスンデバイス（遠隔医療機器）：デバイス種類別・主要国における市場2017-2028 ・企業プロファイル・品質分析・結論・用語集...The Global Telemedicine Devices market shows immense potential to grow in the future, growing in line with some emerging trends. One such trend is the increasing strategic partnerships in a move to introduce or diversify product portfolios pertaining to the delivery of healthcare. It is estimated that in 2025, an estimated 1.56 billion adults will be living with hypertension. Telemedicine can help in better management of these diseases as well as help to reduce associated cost. The sickness, disability or death associated with chronic disease can be avoided through preventive measures and use of telemedicine. Moreover, when an older person...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆